Recent Posts
- Study of CAR T-cell therapy rese-cel in scleroderma enrolling in US
- Ofev effectiveness, safety seen over 3-year SENSCIS extension trial
- Phase 1 trial of CAR T-cell therapy likely to open soon to SSc patients
- Focus of NORD study: Rare disease community’s lived experiences
- Low NK cell levels aid PAH diagnosis in people with SSc: Study
- Poor sleep in scleroderma linked to inadequate sleep hygiene: Study
- Is it normal aging, or is it related to my scleroderma?
- SSc autoantibodies can alter disease course, may affect clinical trials
- Immunosuppressants may help treat scleroderma with heart involvement
- CCL2 gene ID’d as common biomarker in SSc, IPF in new study